Table 3 Clinicopathological data of gliomas patients based on the molecular subgroups
Variable | No | Glioma Molecular subgroups | ||||
|---|---|---|---|---|---|---|
GBM, IDH wildtype | GBM, IDH mutant | 1p/19q codeleted gliomas | Astrocytoma, IDH wildtype | Astrocytoma, IDH mutant | ||
Number of samples | 403 | 245 | 11 | 49 | 43 | 55 |
Age of diagnosis (years) | Median | 63.0 | 44.0 | 48.5 | 57.0 | 38.0 |
Minimum | 18.0 | 17.0 | 27.0 | 16.0 | 23.0 | |
Maximum | 87.0 | 59.0 | 76.0 | 80.0 | 66.0 | |
Sex | Male | 163 | 5 | 34 | 24 | 32 |
Female | 82 | 6 | 15 | 19 | 23 | |
Ratio (M/F) | 2:1 | 0.8:1 | 2:1 | 1.3:1 | 1.4:1 | |
Adjuvant Therapy | Receveid | 211 | 11 | 30 | 27 | 45 |
None | 19 | 0 | 1 | 6 | 3 | |
No data | 15 | 0 | 18 | 10 | 7 | |